Wegovy

Product

Brand name for semaglutide 2.4 mg injection for weight management

9 stories

Study Finds GLP-1 Weight-Loss Drugs May Cause Less Muscle Loss Than Previously Believed

GLP-1 Drug Users Report Emotional Blunting, Raising 'Ozempic Personality' Concerns

Scientists Identify Biological Mechanism Behind Why Ozempic Fails for Some Patients

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

FDA Approves Higher-Dose Wegovy for Weight Loss Treatment

Wegovy Users Face Five Times Greater Risk of Sudden Sight Loss Than Ozempic Users

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections

business72d ago

Hims & Hers Stock Surges Amid Weight-Loss Drug Battle with Novo Nordisk

GLP-1 Weight-Loss Drugs Linked to Bone and Tendon Injuries